Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Public ClinicalTrials.gov record NCT00062660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Safety Study to Evaluate the Safety of Tipranavir Plus Ritonavir When Used in Combination With Other Agents for the Treatment of Patients With HIV Infection Who Have Failed and/or Are Intolerant to Combination Antiretroviral Therapy and Have Limited Treatment Options
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.
Study identification
- NCT ID
- NCT00062660
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2003 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Nov 30, 2016
2003 – 2014
United States locations
- U.S. sites
- 35
- U.S. states
- 23
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1182.58.31 | Scottsdale | Arizona | — | — |
| 1182.58.29 | Los Angeles | California | — | — |
| 1182.58.34 Campus Code 696446 | Los Angeles | California | — | — |
| 1182.58.42 Synergy Hematology/Oncology | Los Angeles | California | — | — |
| 1182.58.43 | Los Angeles | California | — | — |
| 1182.58.03 | San Francisco | California | — | — |
| 1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit | San Francisco | California | — | — |
| 1182.58.37 AIDS Health Care Foundation | Los Angeles | Connecticut | — | — |
| 1182.58.41 Circle Medical, LLC | Norwalk | Connecticut | — | — |
| 1182.58.28 | Washington D.C. | District of Columbia | — | — |
| 1182.58.38 | Miami Beach | Florida | — | — |
| 1182.58.40 Drs. Raben and Feldman Research Associates | South Miami | Florida | — | — |
| 1182.58.23 Hillsborough County Health Department | Tampa | Florida | — | — |
| 1182.58.36 Suite 525 | Atlanta | Georgia | — | — |
| 1182.58.08 | Honolulu | Hawaii | — | — |
| 1182.58.22 | Chicago | Illinois | — | — |
| 1182.58.32 | New Orleans | Louisiana | — | — |
| 1182.58.15 | Boston | Massachusetts | — | — |
| 1182.58.19 Henry Ford Hospital | Detroit | Michigan | — | — |
| 1182.58.04 Kansas City Free Health Clinic | Kansas City | Missouri | — | — |
| 1182.58.25 Wohl Clinic | St Louis | Missouri | — | — |
| 1182.58.02 Wellness Center | Las Vegas | Nevada | — | — |
| 1182.58.09 Polari Medical Group | New York | New York | — | — |
| 1182.58.30 | Chapel Hill | North Carolina | — | — |
| 1182.58.06 University of Cincinnati Medical Center, Infectious diseases | Cincinnati | Ohio | — | — |
| 1182.58.35 | Portland | Oregon | — | — |
| 1182.58.14 | Philadelphia | Pennsylvania | — | — |
| 1182.58.20 University of Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| 1182.58.01 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 1182.58.10 Comprehensive Care Center | Nashville | Tennessee | — | — |
| 1182.58.18 University of Texas Southwest Medical Center at Dallas | Dallas | Texas | — | — |
| 1182.58.07 | Houston | Texas | — | — |
| 1182.58.039 Olmos Park Medical Associates | San Antonio | Texas | — | — |
| 1182.58.11 Swedish Medical Center | Seattle | Washington | — | — |
| 1182.58.44 VW Hospital and Clinics | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00062660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00062660 live on ClinicalTrials.gov.